April 19, 2025 6:22 PM

Latest:

Mako Mining Q4 Earnings: Holding Steady
Newmont Completes $4 Billion Asset Divesture Program
Trump’s Tariff Revenue Reaches $500 Million, Below Trump’s Claims
Ontario to Designate Ring of Fire as Strategic Zone to Expedite Mining
Fyre Festival 2 Postponed (Again) Indefinitely, Ticket Holders Receive Refunds

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

Hydrofarm Holdings

Hydrofarm Projects US$470 – US$490 Million In Net Sales For Fiscal Year 2021

January 7, 2022 12:39 PMJanuary 7, 2022 12:29 PM ER Velasco 0 Comments Hydrofarm Holdings

Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) reaffirmed today its financial outlook for the full fiscal year 2021 ended December 31,

Read more

Latest

Mako Mining Q4 Earnings: Holding Steady
Newmont Completes $4 Billion Asset Divesture Program
Trump’s Tariff Revenue Reaches $500 Million, Below Trump’s Claims
Ontario to Designate Ring of Fire as Strategic Zone to Expedite Mining
Fyre Festival 2 Postponed (Again) Indefinitely, Ticket Holders Receive Refunds
Colombian Government Ends Ceasefire with FARC Breakaway Faction
Whistleblower Claims Musk’s DOGE Team Stole Labor Data
Tariffied! Cleveland-Cliffs Not Immune To Market Meltdown

Video

Full Analysis Latest Resources Video Series

Mako Mining Q4 Earnings: Holding Steady

April 19, 2025 3:33 PM Jay Lutz 0

Fourth quarter earnings are now steadily rolling in from the small scale producers out there, and well, in this environment,

Trending

RCMP Officers Demand Liberal Cabinet To Resign
Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
China Boosts Canadian Oil Imports as Trade War With US Intensifies
Tariffied! Cleveland-Cliffs Not Immune To Market Meltdown
Court Finds Rebel News Failed to Prove It’s Real Journalism

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Stocktwits Partners with Beehiiv to Launch Newsletter Platform for Finance Writers

April 16, 2025 2:54 PM JP Alegre 0

Latest News Resources

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

Home
About
Research
Discover
Contact Us
Disclaimer

Categories

Automotive
Biotech
Bonds
Cannabis
Commentary
Crypto
Education
Energy
Entertainment
Esports
ETFs
Food
Full Analysis
Healthcare
Industrials
Latest
Lithium
Macro
Market Movers
Mental Hurdles
News
Oil
Politics
Psychedelics
Real Estate
Resources
Retail
SPACs
Technology
Video Series

Copyright © 2025 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.